NITINOL DEVICES & COMPONENTS ACQUIRES INTERFACE CATHETER SOLUTIONS TO CREATE CONFLUENT MEDICAL TECHNOLOGIES

  Tags: ,

FREMONT, Calif.–(BUSINESS WIRE)–Nitinol Devices & Components, Inc. (“NDC”), announced today it has successfully completed the acquisition of Interface Catheter Solutions (“Interface”). Reflecting the combination’s expanded strategic breadth, NDC and Interface will create Confluent Medical Technologies (“Confluent Medical”), the leading contract manufacturer of specialized medical devices.

The combined company will leverage the technical expertise of both NDC and Interface in highly precise and demanding medical devices. Additionally, the complementary technology platforms create a unique opportunity to deepen relationships with the existing customer base, particularly in the endovascular, neurovascular, transcatheter heart valve, peripheral vascular, ENT and orthopedic markets.

Interface, a pioneer in medical balloon technology, is the leading contract manufacturer of balloon catheter systems. The company combines best-in-class balloon design and development, high-quality balloon contract manufacturing and deep equipment manufacturing expertise to serve a broad array of medical device customers. Interface specializes in ultra-high-pressure, high-pressure, textured surface and jumbo balloons in addition to full balloon catheter assemblies. The company’s optimized extrusion capabilities, supporting balloon contract manufacturing, produces the highest quality and highest reliability extrusions available in the market.

The combination represents a significant step forward in providing fully integrated solutions to medical device customers. Confluent Medical’s portfolio of services includes:

• Nitinol component contract manufacturing
• Balloon component contract manufacturing
• Balloon catheter assembly contract manufacturing
• Nitinol core guidewire contract manufacturing
• Nitinol device design and testing services
• Balloon catheter design and testing services
• Balloon manufacturing equipment
• Nitinol material
• Extrusion

“The acquisition of Interface reflects our commitment to investing in material science technologies that enable us to best serve the medical device community. The NDC-Interface combination is an excellent strategic fit and we are excited to leverage the key talent and technical expertise of the combined companies to provide world class, differentiated products to our customers” noted Dean Schauer President & Chief Executive Officer.

Tom Duerig, Chief Technology Officer commented, “It has long been a goal of NDC to apply its manufacturing, quality systems and technical expertise beyond Nitinol, broadening the manufacturing and outsourcing solutions we can offer to customers. The exceptional technical strength of Interface with polymers, catheters and balloons provides the perfect opportunity to accomplish just that.”

ABOUT NDC
Improving lives by delivering world class medical devices through innovative material science, engineering and manufacturing. NDC is the largest and market leading contract manufacturer of Nitinol-based medical devices. With manufacturing facilities in Fremont, California and San Jose, Costa Rica, NDC has a proven, 20-year track record of partnering with the medical device community and delivering high-quality Nitinol devices and components in the endovascular, peripheral vascular, cardiovascular and neurovascular spaces. www.nitinol.com.

ABOUT INTERFACE
Interface Catheter Solutions is the leading contract manufacturer of medical balloons and balloon catheter systems. Interface offers balloon design and development, balloon contract manufacturing, extruded balloon tubing, custom medical extrusion and an extensive line of balloon catheter manufacturing and testing equipment. With facilities in Laguna Niguel, California, Interface serves peripheral vascular, ENT, orthopedic, endovascular and cardiovascular medical device customers. www.interfaceusa.com.

Media Contact:

NDC
Samantha Avila, 510-683-2238
Samantha.avila@nitinol.com

‹ MARK LEMMA JOINS NDC  | Confluent Medical Technologies Acquires Biome... ›